Anti-VEGF therapy holds promise for CNV in AMD

July 1, 2002
Laszlo Dosa

Fort Lauderdale, FL-Anti-vascular endothelial growth factor (anti-VEGF) therapy is a promising treatment of neovascularization brought on by various ocular diseases, including age-related macular degeneration (AMD), according to Lawrence J. Singerman, MD.